Improving the lives of people with acute, rare and chronic disorders.
Chiesi USA is the U.S. affiliate of Chiesi Farmaceutici, S.p.A, a global R&D-focused pharmaceutical company located in Parma, Italy. We are a specialty pharmaceutical company committed to the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings.
As an organization, we have a strong track record of performance. This has allowed the company to grow quickly in terms of sales, people and product portfolio. With revenues exceeding $275 million in 2018, Chiesi USA has quickly established itself as a top producing affiliate in the Chiesi worldwide group.
Our primary focus is on people: the people we serve in the healthcare community; the people whose lives are touched by our products and services; and the people who work at Chiesi USA, as they strive to build their company, their family and their community.
CHIESI GROUP
Headquartered in Parma, Italy, Chiesi Farmaceutici is an international research-focused Healthcare group with more than 80 years of experience in the pharmaceutical industry. The privately owned company has a strong focus on research, development, production and the commercialization of innovative medicines in therapeutic areas that include: respiratory, cardiovascular, neonatology, and cystic fibrosis.
The Chiesi Group spans the globe, employing more than 5,300 people in 27 affiliates worldwide and sells its products in more than 80 countries.
